Renal tubular dysfunction has been reported in patients on deferasirox therapy but no systematic study has been performed. This study aimed to determine the cumulative incidence of renal tubular dysfunction and serum electrolyte imbalances among children
Chan, GCF +4 more
core
Impact of iron chelation therapy on thyroid function in beta-thalassemia major patients from Pakistan. [PDF]
Shah AWA +5 more
europepmc +1 more source
Luspatercept in Transfusion-Dependent Thalassemia With Red Blood Cell Antibodies: A Case Series. [PDF]
Teawtrakul N.
europepmc +1 more source
Pharmacogenomic and Clinical Predictors of Deferasirox Response in Transfusion-Dependent Thalassemia Identified Using Whole-Genome Sequencing. [PDF]
Yampayon K +11 more
europepmc +1 more source
Management of iron overload in adult myelodysplastic syndrome. [PDF]
Leitch HA, Buckstein R.
europepmc +1 more source
Therapeutic targeting of the hepcidin-ferroportin axis and erythropoietic modulators: a narrative review. [PDF]
Mansour GK, Hajjar AW, Sajid MR.
europepmc +1 more source
Iatrogenic iron overload caused by iron isomaltoside treatment: A case report. [PDF]
Hu Y +6 more
europepmc +1 more source
Efficacy of combination chelation with deferasirox and deferiprone in children with beta-thalassemia major: an audit from a unit in the developing world. [PDF]
James V, Prakash A.
europepmc +1 more source
Association Between Iron Overload and Glucose Metabolism in Children and Youth with Transfusion-Dependent Beta Thalassemia: The Role of Chelation Therapy. [PDF]
İncefidan İ +3 more
europepmc +1 more source
Hearing assessment in transfusion dependent beta-thalassemia children on oral iron chelating agent. [PDF]
Mohamed WEI +4 more
europepmc +1 more source

